+86(1360)2568149 info@phcoker.com

Raw Liraglutide powder (204656-20-2)

Liraglutide powder (204656-20-2) is a GLP-1 analog and a medication used to treat diabetes mellitus type 2 and obesity. ……

Status: In Mass Production
Synthesized and Customized Available
Capacity: 1277kg/month



Raw Liraglutide powder (204656-20-2) video


Raw Liraglutide powder (204656-20-2) Description

Liraglutide powder (204656-20-2) is a GLP-1 analog and a medication used to treat diabetes mellitus type 2 and obesity. in which lysine at position 34 has been replaced with arginine, and palmitic acid has been attached via glutamoyl spacer to lysine at position 26. No animal-derived raw materials or excipients are used in the production of Raw Liraglutide powder (204656-20-2). The drug product is a solution for subcutaneous injection containing 6.0 mg/ml of the drug substance presented in a pre-filled, multi-dose pen-injector. Unlike GLP-1, Raw Liraglutide powder has a pharmacokinetic and pharmacodynamic profile in human suitable for once daily administration.

Liraglutide powder is also a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing insulin release from the pancreas and decreases excessive glucagon release.

Raw Liraglutide powder (204656-20-2) Specifications

Product Name Liraglutide powder
Chemical Name Glycine,L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];
Brand Name Victoza
Drug Class Peptide
CAS Number 204656-20-2
Molecular Formula C172H265N43O51
Molecular Weight 3751.262 g/mol
Monoisotopic Mass 3748.946 g/mol
Melting Point  >182°C (dec.)
Biological Half-Life approximately 13 hours.
Color N/A
Solubility  Soluble in DMSO
Storage Temperature  Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Application used as a hypoglycemic agent and supplemental therapy in the treatment of Diabetes by patients who do not respond to Metformin, to treat diabetes mellitus type 2 and obesity.



This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.


References & product citations

Liraglutide: A Good Drug For Treating Diabetes Mellitus Type 2 And Obesity